drug

donidalorsen sodium

Marketedupdated 2mo ago

by $IONS IONIS PHARMACEUTICALS INC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 21, 2032

~6.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

May 1, 2035compositionUS 10294477
Aug 28, 2034compositionUS 9670492
May 1, 2034compositionUS 9127276
May 1, 2034compositionUS 9181549
Oct 21, 2032method-of-use (U-3010)US 9315811

Data sources

ClinicalTrials.gov

last refreshed 15m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?